Virological response with fully active etravirine (ETR; TMC125) after 48 weeks of treatment: pooled results from the DUET-1 and DUET-2 trials
In: Journal of the International AIDS Society, Band 11, Heft Suppl 1, S. P23
ISSN: 1758-2652
4 Ergebnisse
Sortierung:
In: Journal of the International AIDS Society, Band 11, Heft Suppl 1, S. P23
ISSN: 1758-2652
In: Population: revue bimestrielle de l'Institut National d'Etudes Démographiques. French edition, Band 48, Heft 3, S. 789
ISSN: 0718-6568, 1957-7966
In: Journal of the International AIDS Society, Band 11, Heft Suppl 1, S. P27
ISSN: 1758-2652
Introduction Surgical oncology is a defined specialty within the European Board of Surgery within the European Union of Medical Specialists (UEMS). Variation in training and specialization still occurs across Europe. There is a need to align the core knowledge needed to fulfil the criteria across subspecialities in surgical oncology. Material and methods The core curriculum, established in 2013, was developed with contributions from expert advisors from within the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy and Oncology (ESTRO) and European Society of Medical Oncology (ESMO) and related subspeciality experts. Results The current version reiterates and updates the core curriculum structure needed for current and future candidates who plans to train for and eventually sit the European fellowship exam for the European Board of Surgery in Surgical Oncology. The content included is not intended to be exhaustive but, rather to give the candidate an idea of expectations and areas for in depth study, in addition to the practical requirements. The five elements included are: Basic principles of oncology; Disease site specific oncology; Generic clinical skills; Training recommendations, and, lastly; Eligibility for the EBSQ exam in Surgical Oncology. Conclusions As evidence-based care for cancer patients evolves through research into basic science, translational research and clinical trials, the core curriculum will evolve, mature and adapt to deliver continual improvements in cancer outcomes for patients.
BASE